Next-generation sequencing approaches to identify driver mutations have greatly enhanced our ability to identify JAK2 mutations in polycythemia (polycythemia vera [PV]) (Stuckey and Gómez-Casares, 2021). The gene discussed is JAK2; the disease is acquired polycythemia vera.